These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26541263)

  • 1. Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus.
    Notsu M; Kanazawa I; Tanaka S; Yamaguchi T; Sugimoto T
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):332-7. PubMed ID: 26541263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes.
    Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
    Calcif Tissue Int; 2009 Sep; 85(3):228-34. PubMed ID: 19641839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
    Kanazawa I; Yamaguchi T; Sugimoto T
    Osteoporos Int; 2011 Apr; 22(4):1191-8. PubMed ID: 20532480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Serum Uric Acid is a Risk Factor of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Tanaka KI; Kanazawa I; Notsu M; Sugimoto T
    Exp Clin Endocrinol Diabetes; 2020 Jan; 128(1):66-71. PubMed ID: 30562825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
    Tanaka KI; Kanazawa I; Kaji H; Sugimoto T
    Bone; 2017 Feb; 95():5-10. PubMed ID: 27836731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus.
    Miyake H; Kanazawa I; Sugimoto T
    Calcif Tissue Int; 2018 Jan; 102(1):1-13. PubMed ID: 28965188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus.
    Tanaka S; Kanazawa I; Notsu M; Sugimoto T
    Diabetes Res Clin Pract; 2016 Jun; 116():1-6. PubMed ID: 27321309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y; Liu X; Xu H
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men.
    Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
    Calcif Tissue Int; 2008 Nov; 83(5):324-31. PubMed ID: 18946627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus.
    Kiyohara N; Yamamoto M; Sugimoto T
    PLoS One; 2015; 10(12):e0144496. PubMed ID: 26642210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum uric acid with bone mineral density and clinical fractures in Chinese type 2 diabetes mellitus patients: A cross-sectional study.
    Yan P; Zhang Z; Wan Q; Zhu J; Li H; Gao C; Ma H; Xu Y
    Clin Chim Acta; 2018 Nov; 486():76-85. PubMed ID: 30031772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice.
    Kanda J; Furukawa M; Izumo N; Shimakura T; Yamamoto N; Takahashi HE; Wakabayashi H
    Drug Discov Ther; 2020 Nov; 14(5):218-225. PubMed ID: 33116039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Sugimoto T
    Diabetes Care; 2009 Dec; 32(12):2263-8. PubMed ID: 19752174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.
    Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
    Eur J Endocrinol; 2009 Feb; 160(2):265-73. PubMed ID: 18996964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening osteoporotic femoral neck without measuring bone mineral density with the use of tartrate resistant acid phosphatase-5b and serum-creatinine-to-cystatin C ratio in Japanese postmenopausal women.
    Yoshii I; Chijiwa T; Sawada N
    J Orthop Sci; 2020 Jul; 25(4):671-676. PubMed ID: 31337577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.